Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -25.6 % |
3 Month Return | -4.13 % |
1 Year Return | + 42.93 % |
Market Stats | |
Previous Close | ₹2,046.00 |
Open | ₹2,052.45 |
Volume | 10.92K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹3,383.88Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹3,383.88 Cr |
P/B Ratio | 6.75 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 25.69 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹3,383.88 Cr | 127.22% | 0.51 | NA | NA | |
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
Organisation | RPG Life Sciences Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for RPG Life Sciences Ltd
RPG Life Sciences reported a 12.13% increase in net sales for September 2024, but net profit fell significantly. The company is exploring acquisitions, backed by a cash surplus of ₹200 crore, as all segments show double-digit growth.
RPG Life Sciences Prepares for Q2 Earnings Release - 31 Oct, 2024
RPG Life Sciences is set to announce its Q2 results on November 7, 2024. The stock gained 2.52% on October 31, closing at Rs 2505.45. Year-to-date, shares are up 88%, with impressive long-term returns.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, RPGLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 1.65% to 2.67% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 1.14% to 1.35% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.81% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 15.6%
Retail Holding Down
Retail Investor have decreased holdings from 21.42% to 20.39% in Sep 2024 quarter
Price Dip
In the last 7 days, RPGLIFE stock has moved down by -5.2%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.81% | 0.00 | |
Foreign Institutions | 1.35% | 17.65 | |
Mutual Funds | 2.67% | 61.58 | |
Retail Investors | 20.39% | ||
Others | 2.78% |
RPG Life Sciences Ltd’s net profit fell -83.76% since last year same period to ₹4.20Cr in the Q2 2024-2025. On a quarterly growth basis, RPG Life Sciences Ltd has generated -84.3% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, RPG Life Sciences Ltd has declared dividend of ₹16 - translating a dividend yield of 0.79%.
Read More about DividendsBearish
Neutral
Bullish
RPG Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
RPG Life Sciences Ltd (RPGLIFE) share price today is ₹2032.25
RPG Life Sciences Ltd is listed on NSE
RPG Life Sciences Ltd is listed on BSE
Today’s traded volume of RPG Life Sciences Ltd(RPGLIFE) is 10.92K.
Today’s market capitalisation of RPG Life Sciences Ltd(RPGLIFE) is ₹3383.88Cr.
RPG Life Sciences Ltd(RPGLIFE | Price |
---|---|
52 Week High | ₹2974.95 |
52 Week Low | ₹1292 |
RPG Life Sciences Ltd(RPGLIFE) share price is ₹2032.25. It is down -31.69% from its 52 Week High price of ₹2974.95
RPG Life Sciences Ltd(RPGLIFE) share price is ₹2032.25. It is up 57.29% from its 52 Week Low price of ₹1292
RPG Life Sciences Ltd(RPGLIFE | Returns |
---|---|
1 Day Returns | -13.75% |
1 Month Returns | -25.6% |
3 Month Returns | -4.13% |
1 Year Returns | 42.93% |